本文就作者在论文审阅和新药审评中发现的一些问题提出个人观点。
This paper gives some personal views on the problems in new drug evaluation and thesis check of polysaccharides.
这对于那些因高剂量毒副作用太大而未通过新药审评的药物而言,无疑为其用于临床开辟了一条新的途径。
This could open the door for a lot of drugs that have failed to be approved because they caused too many side effects at a higher dose.
这对于那些因高剂量毒副作用太大而未通过新药审评的药物而言,无疑为其用于临床开辟了一条新的途径。
This could open the door for a lot of drugs that have failed to be approved because they caused too many side effects at a higher dose.
应用推荐